Regulation of cell-­nonautonomous proteostasis in metazoans

Cells have developed robust adaptation mechanisms to survive environmental conditions that challenge the integrity of their proteome and ensure cellular viability. These are stress-­signalling pathways that integrate extracellular signals with the ability to detect and efficiently respond to protein-­folding perturbations within the cell. Within the context of an organism, the cell autonomous effects of these signalling mechanisms are superimposed by cell-­nonautonomous stress signalling pathways that allow coordination of stress responses across tissues. These transcellular stress signalling pathways orchestrate and maintain the cellular proteome at an organismal level. This review focuses on mechanisms in both invertebrate and vertebrate organisms that activate stress responses in a cell-­nonautonomous manner. We discuss emerging insights and provide specific examples on how components of the cell-­nonautonomous proteostasis network are used in cancer and protein-­folding diseases to drive disease progression across tissues

A PQM-1-mediated response triggers transcellular chaperone signaling and regulates organismal proteostasis

In metazoans, tissues experiencing proteotoxic stress induce “transcellular chaperone signaling” (TCS) that activates molecular chaperones, such as hsp-90, in distal tissues. How this form of inter-tissue communication is mediated to upregulate systemic chaperone expression and whether it can be utilized to protect against protein misfolding diseases remain open questions. Using C. elegans, we identified key components of a systemic stress signaling pathway that links the innate immune response with proteostasis maintenance. We show that mild perturbation of proteostasis in the neurons or the intestine activates TCS via the GATA zinc-finger transcription factor PQM-1. PQM-1 coordinates neuron-activated TCS via the innate immunity-associated transmembrane protein CLEC-41, whereas intestine-activated TCS depends on the aspartic protease ASP-12. Both TCS pathways can induce hsp-90 in muscle cells and facilitate amelioration of Aβ₃-₄₂-associated toxicity. This may have powerful implications for the treatment of diseases related to proteostasis dysfunction